You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Julie Langelier, Science Writer and Public Relations Specialist

Direct line: 415.734.5000

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019


 

Press Releases

November 2, 2017

Study may lead to new treatments for diseases like multiple sclerosis

October 10, 2017

Scientists develop a cheaper, quicker, and more reliable stem cell–based technology to facilitate drug discovery

October 5, 2017

The term begins on January 1, 2018

September 21, 2017

A new center at Gladstone aims to find unforeseen uses for existing drugs

September 5, 2017

An unexpected collaboration leads to the discovery of an early predictor of IBD

August 24, 2017

A single drug could attack the virus on two fronts

August 2, 2017

The discovery could improve treatments for autoimmune diseases and cancer

July 20, 2017

Studer was selected for his groundbreaking research in stem cell–based therapies for Parkinson’s disease

July 12, 2017

E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders

June 27, 2017

Researchers show that semen amyloids help the human body dispose of excess and defective sperm

Pages